Biotech Blog Archives: June 2003
next page ·
30 June 2003
Biogen/Idec: still a matter of size
Biogen/Idec: still a matter of size
The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help the two relatively isolated companies increase presence in their disease areas. The annual R&D budget for the new pharmaceutical entity, to be called Biogen Idec Inc, will be $500 million, according to company reports.
continue reading... » 0 Comments
19 June 2003
The State of Biotechnology
The State of Biotechnology
Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry Organization’s annual convention. Topics to be addressed at BIO 2003 range from science and regulatory affairs to bioethics and homeland security.
continue reading... » 0 Comments
19 June 2003
Coffee Plants Can Produce Less Caffeine
Coffee Plants Can Produce Less Caffeine
Researchers say they have genetically engineered coffee plants that have 70 percent less caffeine than usual in their leaves. The crucial question for brewing coffee � whether beans from those plants will have less caffeine � won’t be known for three to four years when the plants mature
continue reading... » 0 Comments
19 June 2003
Pfizer’s Outlook Improves
Pfizer’s Outlook Improves
Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the drug world. And with its $60 billion Pharmacia merger completed in April, the king just got fatter
continue reading... » 0 Comments
19 June 2003
Schering’s Dr. Feelbetter?
Schering’s Dr. Feelbetter?
Fred Hassan is out to revive the drugmaker. It’s a big job
continue reading... » 0 Comments
19 June 2003
FDA approves first nasal mist flu vaccine
FDA approves first nasal mist flu vaccine
Most people who avoid flu shots because they fear needles will not have that excuse this season. The Food and Drug administration has approved a flu vaccine that is delivered by a squirt up the nose instead of a shot in the arm.
